Compliance with RSV prophylaxis: Global physicians’ perspectives

Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxis (monthly doses during the RSV season) is essential to ensure protection. We invited 453 pediatricians to participate in a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Anderson, Kari S, Mullally, Victoria M, Fredrick, Linda M, Campbell, Andrew L
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2009
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778415/
https://ncbi.nlm.nih.gov/pubmed/19936162
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk